ocrelizumab fda approval multiple sclerosis

Keyword Analysis

Keyword	CPC	PCC	Volume	Score	Length of keyword
ocrelizumab fda approval multiple sclerosis	1.53	0.3	839	34	43
ocrelizumab	0.57	0.5	4539	64	11
fda	0.59	0.9	7805	6	3
approval	0.76	1	5186	28	8
multiple	0.22	0.5	7069	49	8
sclerosis	0.25	0.3	9716	85	9

Keyword	CPC	PCC	Volume	Score
ocrelizumab fda approval multiple sclerosis	1.02	0.8	6379	15
ocrelizumab used for multiple sclerosis	1.47	0.6	4156	40
ofatumumab multiple sclerosis fda approval	0.43	0.3	4662	51
fda approved multiple sclerosis drugs	0.46	0.9	6550	77
ocrelizumab primary progressive ms	1.55	0.3	2283	59
ms infusion ocrelizumab reviews	0.32	0.7	5001	10
ublituximab fda approval multiple sclerosis	0.36	0.1	5074	69
ms infusion ocrelizumab vs ocrevus	1.89	0.3	6843	64
opicinumab multiple sclerosis approved	1.28	1	8007	83
ocrelizumab and fda indications	1.97	0.1	6657	77
ocrelizumab multiple sclerosis side effects	1.06	0.5	6886	19
ofatumumab fda approval for ms	1.75	0.2	3053	68
multiple sclerosis approved drugs	0.25	0.3	2653	53
brand name of ocrelizumab	1.51	0.2	4637	73
ann 2023 ofatumumab multiple sclerosis	1.73	0.7	9421	50
ms infusion ocrelizumab infusion protocol	0.78	0.4	5411	95
new multiple sclerosis medicine	1.15	0.1	659	95
is ocrelizumab an immunosuppressant	0.58	0.3	6698	41
ocrelizumab people also search for	1.61	0.6	947	16
how much does ocrelizumab cost	0.99	0.2	4308	69
new ms medication ocrevus	1.5	0.4	3656	62